NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $228 | -99.9% | 100,945 | -1.2% | 0.02% | -36.0% |
| Q3 2022 | $327,000 | -12.8% | 102,178 | +3.6% | 0.02% | -7.4% |
| Q2 2022 | $375,000 | -28.0% | 98,609 | +1.9% | 0.03% | -18.2% |
| Q1 2022 | $521,000 | -59.9% | 96,742 | +0.5% | 0.03% | -58.2% |
| Q4 2021 | $1,300,000 | -24.6% | 96,245 | +0.2% | 0.08% | -30.1% |
| Q3 2021 | $1,725,000 | +5.1% | 96,022 | +0.4% | 0.11% | +6.6% |
| Q2 2021 | $1,642,000 | -12.8% | 95,677 | +1.6% | 0.11% | -17.8% |
| Q1 2021 | $1,883,000 | +15.2% | 94,163 | -2.1% | 0.13% | +11.2% |
| Q4 2020 | $1,635,000 | +1.9% | 96,167 | -0.5% | 0.12% | -10.1% |
| Q3 2020 | $1,604,000 | -28.1% | 96,666 | +0.3% | 0.13% | -34.2% |
| Q2 2020 | $2,232,000 | +21.7% | 96,362 | -6.2% | 0.20% | +16.7% |
| Q1 2020 | $1,834,000 | -16.0% | 102,757 | +1.6% | 0.17% | +1.2% |
| Q4 2019 | $2,184,000 | +19.1% | 101,163 | +0.5% | 0.17% | +7.8% |
| Q3 2019 | $1,833,000 | -45.6% | 100,656 | +6.2% | 0.15% | -43.4% |
| Q2 2019 | $3,372,000 | +7.4% | 94,789 | +1.5% | 0.27% | +3.4% |
| Q1 2019 | $3,139,000 | +70.3% | 93,434 | +66.7% | 0.26% | +58.4% |
| Q4 2018 | $1,843,000 | -45.3% | 56,057 | +1.4% | 0.17% | -35.4% |
| Q3 2018 | $3,370,000 | +24.0% | 55,281 | -0.7% | 0.26% | +31.1% |
| Q2 2018 | $2,717,000 | – | 55,645 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |